Immunotherapy improves survival in metastatic or recurrent head and neck cancer
byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.
Updated on: December 18,2023
Immunotherapy improves survival in metastatic or recurrent head and neck cancer
byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.
Updated on:December 18,2023
